Industry

DUBLIN–(BUSINESS WIRE)–The “Cell-Free RNA Isolation and Extraction Kits Market – A Global and Regional Analysis: Focus on Application, End User, and Region – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$JANX—Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the appointment of Winston Kung to the Company’s Board of Directors. Janux also announced that Stefan … [Read more…]

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. today announced the winners of their clinical performance and supply chain excellence awards for 2022. The awards, which recognize the work of member health systems in the areas of clinical quality and accountability, supplier diversity and environmentally preferred sourcing, were presented during the 2022 Vizient Connections Summit held Sept. 19-21 in … [Read more…]

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the third quarter of 2022 on November 3, 2022 after the close of the financial markets. In connection with the release, management … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global peptide therapeutics market is expected to grow at a CAGR of around 9.5% during 2022-2028. This report on global peptide therapeutics market report provides holistic understanding of the market along with market sizing, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wearable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. This report on the global wearable medical devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market … [Read more…]

HSINCHU, Taiwan–(BUSINESS WIRE)–#NTHU–On August 20, the Tsing Hua University Hospital Preparatory Office was officially opened in the Xinkong Building at the Taoyuan Metro Corporation’s Qingpu Depot, which is only one MRT station away from the site where the Hospital will be built. NTHU and the Taoyuan City Government have already signed a letter of intent … [Read more…]

Continued progress toward planned development for SENS-401 and gene therapy programs Positive progress for two clinical trials for SENS-401: in Cisplatin-Induced Ototoxicity (CIO) and to prevent residual hearing loss following cochlear implantation Development milestone achieved for the OTOF-GT program with delivery of batches for the toxicology study; plan to file Clinical Trial Application in 1H … [Read more…]

HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its Chief Executive Officer, Dr. Sherif Abdou, will participate on the “Next Frontier – Value Based Care for Sub-Capitation/Specialties” virtual panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22nd at 9:00 am … [Read more…]

Initial safety run‐in results from LOTIS-5 Phase 3 trial demonstrate ORR of 75% and 40% CR rate with no new safety signals Cami pivotal Phase 2 data to be highlighted in encore oral and poster presentations LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today announced that ZYNLONTA® (loncastuximab tesirine-lpyl) and camidanlumab tesirine (Cami) abstracts have … [Read more…]